Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives.

Rawal N, Batra S, Sharma T, Nagararja S, Singh S, Ranjan R, Kumar V, Raj Pal R

DOI: 10.2174/0113816128470361260803050708
Published: 2026 Aug 19
Container: Current pharmaceutical design
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0113816128470361260803050708,
  title = {Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives.},
  author = {Rawal N and Batra S and Sharma T and Nagararja S and Singh S and Ranjan R and Kumar V and Raj Pal R},
  year = {2026},
  journal = {Current pharmaceutical design},
  doi = {10.2174/0113816128470361260803050708},
  url = {https://doi.org/10.2174/0113816128470361260803050708}
}

RIS

TY  - JOUR
TI  - Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives.
AU  - Rawal N
AU  - Batra S
AU  - Sharma T
AU  - Nagararja S
AU  - Singh S
AU  - Ranjan R
AU  - Kumar V
AU  - Raj Pal R
PY  - 2026
JO  - Current pharmaceutical design
DO  - 10.2174/0113816128470361260803050708
UR  - https://doi.org/10.2174/0113816128470361260803050708
ER  -

APA

N, R., S, B., T, S., S, N., S, S., R, R., V, K., & R, R. P. (2026). Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives.. Current pharmaceutical design. https://doi.org/10.2174/0113816128470361260803050708

Source records

pubmed · retrieved 2026-09-26T04:28:14.295Z